VTGN   $2.9699999999999998  -1.98% Market Closed After Close 3.07 3.37%

Vistagen Therapeutics Inc
Total Cash 108.36M
totalCashPerShare 4.005
EBITDA -38.02M
Total Debt 1.99M
quickRatio 17.377
currentRatio 17.774
Total Revenue 971.00K
debtToEquity 1.899
Revenue/Share 0.039
ROA -0.37092
ROE -0.59456
grossProfits
freeCashflow -18.21M
operatingCashflow -28.79M
earningsGrowth
revenueGrowth -0.525
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -144.41667
profitMargins 0.0
enterpriseValue -21.15M
forwardPE -1.8128654
floatShares 15.84M
sharesOutstanding 27.06M
sharesShort 644.72K
sharesShortPriorMonth 738.26K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.59%
Short Ratio help_outline 4.13%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 3.874
Price To Book help_outline 0.80
earningsQuarterlyGrowth
netIncomeToCommon -33.19M
trailingEps -0.93%
forwardEps -1.71%
enterpriseToEbitda 0.56
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.39 3Q 2024
institutionsCount 53
lastUpdated Nov. 7, 2024, 2:27 a.m.